APA (7th ed.) Citation

Raut, S. B., Joly, F., Haass, N. K., Eri, R., Canales, J. J., Benedek, D. M., . . . Johnson, L. R. The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD models. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Raut, Sanket B., Fanny Joly, Nikolas K. Haass, Rajaraman Eri, Juan J. Canales, David M. Benedek, Robert J. Ursano, and Luke R. Johnson. The Clinically Relevant MEK Inhibitor Mirdametinib Combined with D-cycloserine and Prediction Error Disrupts Fear Memory in PTSD Models. Nature Publishing Group.

MLA (9th ed.) Citation

Raut, Sanket B., et al. The Clinically Relevant MEK Inhibitor Mirdametinib Combined with D-cycloserine and Prediction Error Disrupts Fear Memory in PTSD Models. Nature Publishing Group.